Wuxi Biologics Placement - Similar Deal Will Yield Similar Results
Wuxi Biologics Holdings is looking to raise up to US$1.3bn by selling about 1.8% of Wuxi Biologics (2269 HK). This is the company's 15th placement...
347 Views
Pre-IPO Novotech Holdings - The Future Would Not Be Easy
This article analyzed Novotech in terms of the industry characteristics, comparison with peers (revenue growth rate, margins, etc.), the concerns...
568 Views
LinkDoc Technology (LDOC.US) - Here Are the Concerns
This article mainly analyzed concerns on LinkDoc in terms of main revenue source, profitability compared with peers, investment in R&D, barriers on...
233 Views
Pre-IPO Shanghai Haoyuan Chemexpress - A New CRO/CDMO with Continued High Growth Potential
As CRO/CDMO continues to be a hot sector for investors and have outstanding performance, the new pre-IPO company Haoyuan Chemexpress with high...
193 Views
Novotech Pre-IPO: Biotech Focused CRO at Hefty Pre-IPO Valuation
Novotech has an interesting value proposition as a biotech focused CRO in the APAC region. The company has a decent growth in the past but we think...
782 Views